Skip to main content
Clinical Trials/NCT07309016
NCT07309016Not yet recruitingNot Applicable

The Effect of a Weighted Blanket on Lower Leg Cramps, Sleep Quality, Anxiety, and Stress in Pregnant Women: A Randomized Controlled Trial

Ataturk University2 sites in 1 country50 target enrollmentStarted: December 30, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
50
Locations
2
Primary Endpoint
Pittsburgh Sleep Quality Index - PSQI

Study Overview

Brief Summary

Pregnancy is frequently accompanied by sleep disturbances, musculoskeletal discomfort, anxiety, and stress, which may negatively affect maternal well-being and daily functioning. Weighted blankets, which provide deep pressure stimulation, have been used as a non-pharmacological method to promote relaxation, improve sleep quality, and reduce stress and anxiety. However, their effects have not been evaluated in pregnant women. This study aims to examine the effect of weighted blanket use on lower leg cramps, sleep quality, anxiety, and stress levels among pregnant women. The trial uses a randomized, self-controlled design in which each participant completes a 14-day control period without the blanket and a subsequent 14-day intervention period using the weighted blanket. Data will be collected using validated measurement tools. The findings are expected to provide evidence for a safe, non-pharmacological supportive approach that may enhance comfort and psychological well-being during pregnancy.

Detailed Description

Pregnancy involves physiological and psychological changes that may contribute to sleep difficulties, lower extremity cramping, and increased levels of anxiety and stress. Because pharmacological approaches are often limited during pregnancy, non-pharmacological strategies are important for promoting maternal comfort and well-being. Weighted blankets provide evenly distributed pressure across the body, generating deep pressure stimulation that may induce relaxation, reduce arousal, and support more stable sleep patterns.

This study is designed as a randomized, self-controlled trial to evaluate the effects of weighted blanket use on sleep quality, lower leg cramps, anxiety, and stress in pregnant women. The study includes one group of participants who undergo two consecutive phases:

Control Phase (14 days): Participants complete daily sleep diaries and standardized assessments without using a weighted blanket.

Intervention Phase (14 days): Participants receive an 8-kg glass-bead weighted blanket and use it during the sleep initiation period (approximately 40 minutes each night). Daily sleep diaries and standardized assessments are repeated following the intervention.

To support participant safety, the blanket weight will not exceed 8-10% of body weight, and participants will be instructed to use the blanket only during sleep onset. Participants will receive guidance on maintaining a safe sleep posture, particularly the left lateral position. Weekly follow-up phone calls will be conducted to monitor adherence, comfort, and potential adverse effects.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Primarily pregnant women between the ages of 18 and 40 ,
  • Low BMI (to be able to use 8kg weighted blanket),
  • Gestational week ≥ 28,
  • Third trimester pregnant women,
  • Singleton pregnancy,
  • Ability to communicate verbally and in writing in Turkish,
  • Willingness to participate in research and comply with intervention protocols..

Exclusion Criteria

  • Those who have been diagnosed with high-risk pregnancy,
  • Preeclampsia or eclampsia, placenta previa,
  • Gestational diabetes requiring insulin,
  • Diagnosis of fetal growth retardation,
  • Polyhydramnios or oligohydramnios, asthma , sleep apnea or serious heart/circulatory problems,
  • History of bleeding during pregnancy,
  • Obstetric complications requiring close medical monitoring.
  • Multiple pregnancies,
  • Previously diagnosed with a sleep disorder,
  • Having been diagnosed with a psychiatric disorder
  • Multiparous pregnant women,
  • Pregnant women in the first two trimesters ,
  • Night shift workers

Outcomes

Primary Outcomes

Pittsburgh Sleep Quality Index - PSQI

Time Frame: Baseline (Day 0-14; control phase) Post-intervention (Day 15-28; after weighted blanket use)

Sleep quality will be assessed using the Pittsburgh Sleep Quality Index, a validated 19-item instrument that generates a total score based on seven components of sleep. Total PSQI scores range from 0 to 21, with higher scores indicating poorer sleep quality. The change in PSQI total score from baseline (control period) to post-intervention will be evaluated.

Leg Cramp Questionnaire Form

Time Frame: Baseline (Day 0-14; control phase) Post-intervention (Day 15-28)

Lower leg cramps will be evaluated using participant-reported frequency (number of cramps per week) and severity (rated on a 0-10 Numeric Rating Scale, where 0 = no pain and 10 = most severe pain). Changes between the 14-day control phase and the 14-day intervention phase will be assessed.

Perinatal Anxiety Screening Scale (PASS)

Time Frame: Baseline (after 14-day control phase) Post-intervention (after 14 days of weighted blanket use)

Anxiety levels will be assessed using the Perinatal Anxiety Screening Scale, a validated 31-item instrument. The total PASS score ranges from 0 to 93, with higher scores indicating greater perinatal anxiety. Total scores will be compared before and after the intervention.

Pregnancy Stress Rating Scale

Time Frame: Baseline (after 14-day control phase) Post-intervention (after 14 days of weighted blanket use)

Pregnancy-related stress will be measured using the Pregnancy Stress Rating Scale, a validated 36-item scale. Total scores range from 0 to 144, with higher scores reflecting higher levels of pregnancy-related stress. The change in PSRS total score from baseline to post-intervention will be evaluated.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Serap Ejder Apay

Professor of Midwifery and Head of the Department of Midwifery

Ataturk University

Study Sites (2)

Loading locations...

Similar Trials